Strategic Risk LLC. 13D and 13G filings for NeuroBo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-28 3:30 pm Purchase |
2023-03-21 | 13G | NeuroBo Pharmaceuticals, Inc. NRBO |
Strategic Risk LLC. | 150,354 6.300% |
150,354 (New Position) |
Filing |
| 2023-03-27 4:36 pm Purchase |
2023-03-21 | 13G | NeuroBo Pharmaceuticals, Inc. NRBO |
Strategic Risk LLC. | 150,354 6.300% |
150,354 (New Position) |
Filing |